CARLSBAD, CA / ACCESSWIRE / February 22, 2017 / Iso International, LLC (Isodiol) announces that it has granted an exclusive distribution agreement to Laguna Blends, Inc. (CNSX: LAG) (OTC PINK: LAGBF) (FSE: LB6A.F) for Canada. As one of the world's leading suppliers, formulators and manufacturers of pharmaceutical grade CBD products, Isodiol embraces this partnership with Laguna Blends and looks forward to providing its experience in research, development and manufacturing to support the company's vibrant growth. This agreement entails Isodiol offering all of its current products to Laguna on an exclusive basis for the Canadian market.
Isodiol CEO Jared Berry said of this move, "Isodiol has experienced exponential growth each year since our inception. We believe in the integrity of the Laguna Blends brand and growth strategy and look forward to supplying our superior quality CBD products as they expand throughout Canada." Berry added, "We feel confident that the combined benefit of nature and science that powers our superior products will help Laguna meet or exceed its projected sales goals."
This exclusive license and distribution agreement between Laguna and Isodiol details the pursuit of mutually beneficial business opportunities in the Cannabidiol (CBD) Industry in Canada. In Q4 2016, Isodiol recorded unaudited sales of $3,149,738 in CBD related sales in North America. Under the terms of the agreement, Laguna agrees to build on this success and to issue 3,750,000 common shares (the "Consideration Shares").
"Laguna is thrilled to align with Isodiol and expand with the track record and quality of its products and business model," said Ray Grimm Jr., President & CEO of Laguna Blends. "We are currently in negotiations with a third party in Canada that has extensive distribution channels for CBD and hemp products and look forward to this strategic growth."
ISO International COO, Troy Nihart stated, "The Canadian market is ripe for this expansion with Laguna Blends. We intend to work with Laguna and utilize our proprietary extraction methods to secure us as the leading supplier of pharmaceutical grade CBD in Canada. The marketplace there is quickly shifting along with the legal landscape in Canada, and we are now poised to integrate there in beneficial ways."
About Iso International, LLC. (Isodiol)
Isodiol and its team of collaborators are a group of companies that together, grow & harvest hemp on an industrial scale, and then process it to extract the non- psychoactive cannabidiol (CBD) to the highest available purity for worldwide distribution. By utilizing one of the world's largest hemp farms, Isodiol and its partners are the choice for industrial volumes of high-grade, non-psychotropic CBD. Pharmaceutical, nutraceutical and cosmetic companies worldwide have gained market share due to its products. Isodiol's proprietary purification process is ISO 9001 certified. This federal certification holds the company, processes, and products to the highest of standards. To follow Isodiol online, visit the Company's website at http://www.isodiol.com or Facebook, Instagram, and Twitter.
About Laguna Blends, Inc.
Laguna Blends is a market leader in the distribution of Hemp and CBD products. Laguna's growth strategy includes acquiring and incubating companies who formulate and or manufacture Hemp products. Laguna Blends markets Hemp products utilizing its B-to-B Network along with driving traffic to its Laguna Blends online marketplace.
It's Lagunas intent to provide the highest quality hemp product experience for the end user, utilizing a proprietary nanotechnology in many of its consumable and topical skin care products. Laguna is currently seeking joint ventures and acquisitions to expand its portfolio and will aggressively begin international expansion into Asia and Europe in 2017. To follow Laguna Blends online, visit the company's websites or social media: https://lagunablends.com/ or https://cbdskincream.com/
Facebook: https://www.facebook.com/LagunaBlends/
Twitter: @LagunaBlends
Corporate Communications: Howe & Bay Financial: 604-449-5302
Forward-Looking Information: This news release contains "forward-looking information" within the meaning of applicable securities laws relating to statements regarding the Company's business, products and future the Company's business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
DISCLAIMER
Any and all statements made in this article in regard to Isodiol and its CBD/Cannabidiol products are not expressed as medical claims. Our intention is to initiate conversation, not to suggest results nor to encourage action on the part of the reader. Isodiol is not responsible for, and expressly disclaims all liability for, damages of any kind arise out of use, reference to, or reliance on any information contained herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat, or cure any disease. Always check with your physician before starting a new dietary supplement program.
LEGAL DISCLOSURE
Isodiol does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). Cannabidiol is a natural element of industrial hemp. Isodiol's products are not intended to cure, treat or mitigate any disease states.
SOURCE: Isodiol
ReleaseID: 455670
